Value-Added Product and Technology Development by MP五協フード＆ケミカル
First written in FY2024-Q1. 5 of 7 entries say "Advanced", first in FY2024-Q2. Latest entry: FY2026.
115 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「Total research and development expenses for the current consolidated fiscal year amounted to ¥1,512 million.」
Research and development expenses increased from ¥1,418 million in the previous fiscal year to ¥1,512 million. Research continued on rare disease treatments at JCR, testing at プリメディカ, robotic arms at PALTAC, and polysaccharides, biodegradable plastics, electronic chemicals, and other areas at MP五協F&C. - FY2026-H1RestatedAnnual report
「Research and development expenses for the current interim consolidated fiscal year amounted to ¥576 million. There were no significant changes in the Group’s research and development activities during the current interim consolidated fiscal year.」
Research and development expenses amounted to ¥576 million for the interim period, and no significant changes were reported in research and development activities, including those of MP五協フード＆ケミカル and other companies. - FY2025AdvancedAnnual report
「Total research and development expenses for the current consolidated fiscal year amounted to ¥1,418 million.」
Research and development expenses totaled ¥1,418 million. Research was conducted on clinical trials related to JCRファーマ, testing by プリメディカ, robotic arms for PALTAC, and polysaccharides, biodegradable plastics, electronic chemicals, and other areas at MP五協フード＆ケミカル. - FY2025-H1AdvancedAnnual report
「Research and development expenses for the current interim consolidated fiscal year amounted to ¥590 million. There were no significant changes in the Group’s research and development activities during the current interim consolidated fiscal year.」
Research and development expenses for the current interim period were disclosed as ¥590 million, and initiatives in new product and technology development, including those of MP五協フード＆ケミカル, continued. - FY2024AdvancedAnnual report
「Total research and development expenses for the current consolidated fiscal year amounted to ¥991 million.」
Research and development activities, including those of MP五協フード＆ケミカル, totaled ¥991 million, with development proceeding in areas including thickening polysaccharides for foods for elderly care, biodegradable plastic-related materials, and electronic chemicals for semiconductor manufacturing. - FY2024-Q2AdvancedAnnual report
「Research and development expenses for the cumulative second quarter of the current consolidated fiscal year amounted to ¥371 million. Following the inclusion of MP五協フード＆ケミカル㈱ as a consolidated subsidiary at the end of the previous consolidated fiscal year, research and development activities are newly being conducted in the animal pharmaceuticals, food-processing raw materials wholesale, and related businesses. Based on its basic policy of “striving to create value-added products through technological innovation and working toward sustainable growth,” MP五協フード＆ケミカル㈱ is developing high-value-added new products, strengthening the foundations for technology development, and providing strategic, timely technical support.」
Research and development expenses for the cumulative second quarter of the current fiscal year, including the research and development activities of MP五協フード＆ケミカル, amounted to ¥371 million. New product development, strengthening of the technology development base, and technical support have continued since it became a consolidated subsidiary. - FY2024-Q1First statedAnnual report
「Following the inclusion of MP五協フード＆ケミカル㈱ as a consolidated subsidiary at the end of the previous consolidated fiscal year, research and development activities are newly being conducted in the animal pharmaceuticals, food-processing raw materials wholesale, and related businesses. Based on its basic policy of “striving to create value-added products through technological innovation and working toward sustainable growth,” MP五協F&C is developing high-value-added new products, strengthening the foundations for technology development, and providing strategic, timely technical support. In the food sector, it is primarily developing thickening polysaccharides for foods for elderly care, while in the chemical products sector it is developing biodegradable plastic-related materials for a society moving away from plastics and conducting research and development on electronic chemicals essential to semiconductor manufacturing.」
Following the inclusion of MP五協フード＆ケミカル as a consolidated subsidiary, research and development activities were newly disclosed as initiatives of businesses included in the scope of consolidation. Research and development expenses amounted to ¥187 million in FY2024-Q1, with development underway in areas including thickening polysaccharides for foods for elderly care, biodegradable plastic-related materials, and electronic chemicals for semiconductor manufacturing.